BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hull BP, Chandra RK. Refractory Chronic Rhinosinusitis with Nasal Polyposis. Otolaryngol Clin North Am 2017;50:61-81. [PMID: 27888916 DOI: 10.1016/j.otc.2016.08.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Aldinger JP, Dobyns T, Lam K, Han JK. The role of omalizumab in the treatment of chronic rhinosinusitits with nasal polyposis. Expert Opin Biol Ther 2021;:1-7. [PMID: 34334061 DOI: 10.1080/14712598.2021.1962282] [Reference Citation Analysis]
2 Ryu G, Cho YS, Hong SD, Kim HY, Chung S, Dhong H. The Effect of Triamcinolone-Soaked Gelfoam in Patients with Polypoid Mucosal Change after Endoscopic Sinus Surgery. J Rhinol 2020;27:16-20. [DOI: 10.18787/jr.2019.00288] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Dai J, Huai, Xu M, Cai J, Wang H. Revision endoscopic frontal sinus surgery for refractory chronic rhinosinusitis via modified agger nasi approach. J Int Med Res 2021;49:300060521995273. [PMID: 33866841 DOI: 10.1177/0300060521995273] [Reference Citation Analysis]
4 Lelegren MJ, Son SY, Han JK, Lam KK. A review of phase III clinical trials of US FDA-approved biologic therapies for chronic rhinosinusitis with nasal polyposis. Immunotherapy 2022. [PMID: 35510314 DOI: 10.2217/imt-2021-0310] [Reference Citation Analysis]
5 Maniu AA, Perde-Schrepler MI, Tatomir CB, Tănase MI, Dindelegan MG, Budu VA, Rădeanu GD, Cosgarea M, Mogoantă CA. Latest advances in chronic rhinosinusitis with nasal polyps endotyping and biomarkers, and their significance for daily practice. Rom J Morphol Embryol 2020;61:309-20. [PMID: 33544783 DOI: 10.47162/RJME.61.2.01] [Reference Citation Analysis]
6 Yang N, Cheng H, Mo Q, Zhou X, Xie M. miR‑155‑5p downregulation inhibits epithelial‑to‑mesenchymal transition by targeting SIRT1 in human nasal epithelial cells. Mol Med Rep 2020;22:3695-704. [PMID: 33000196 DOI: 10.3892/mmr.2020.11468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Okazaki K, Tsuzuki K, Hashimoto K, Nishikawa H, Takebayashi H, Oka H, Kojima Y, Yukitatsu Y, Mishiro Y, Sakagami M. Usefulness of our proposed olfactory scoring system during endoscopic sinus surgery in patients with chronic rhinosinusitis. Eur Arch Otorhinolaryngol 2018;275:415-23. [PMID: 29204922 DOI: 10.1007/s00405-017-4831-1] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
8 Sindwani R, Han JK, Soteres DF, Messina JC, Carothers JL, Mahmoud RA, Djupesland PG. NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps. Am J Rhinol Allergy 2019;33:69-82. [PMID: 30477309 DOI: 10.1177/1945892418810281] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
9 Ryu G, Kim DK, Dhong HJ, Eun KM, Lee KE, Kong IG, Kim H, Chung SK, Kim DY, Rhee CS, Cho SH, Hong SD, Kim DW. Immunological Characteristics in Refractory Chronic Rhinosinusitis with Nasal Polyps Undergoing Revision Surgeries. Allergy Asthma Immunol Res 2019;11:664-76. [PMID: 31332978 DOI: 10.4168/aair.2019.11.5.664] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
10 Boyle JV, Lam K, Han JK. Dupilumab in the treatment of chronic rhinosinusitis with nasal polyposis. Immunotherapy 2020;12:111-21. [DOI: 10.2217/imt-2019-0191] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Leopold DA, Elkayam D, Messina JC, Kosik-Gonzalez C, Djupesland PG, Mahmoud RA. NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis. J Allergy Clin Immunol 2019;143:126-134.e5. [PMID: 29928924 DOI: 10.1016/j.jaci.2018.06.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]